Westfield Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.17M Sell
17,047
-5
-0% -$1.71K 0.02% 231
2026
Q1
$6M Buy
+17,052
New +$6.08M 0.03% 199
2014
Q2
Sell
-234,431
Closed -$28.9M 314
2014
Q1
$28.9M Sell
234,431
-809,927
-78% -$98.2M 0.17% 174
2013
Q4
$119M Sell
1,044,358
-158,193
-13% -$18M 0.7% 47
2013
Q3
$135M Buy
+1,202,551
New +$130M 0.86% 30

Other funds holding AMGN

Westfield Capital Management's AMGN Position: Q2 2026 in Review

Westfield Capital Management reduced its Amgen (AMGN) stake by 0.03% in Q2 2026, selling an estimated $1.71K and leaving 17,047 shares worth $6.17M. The position accounts for 0.02% of the portfolio, ranked #231.

Westfield Capital Management first reported a position in AMGN in Q3 2013 and has held it in 5 quarters since. The position peaked at $135M in Q3 2013. 3,150 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Westfield Capital Management held 17,047 shares of Amgen worth $6.17M as of Q2 2026.
  • Westfield Capital Management sold 5 Amgen shares in Q2 2026, an estimated $1.71K.
  • Amgen made up 0.02% of Westfield Capital Management's portfolio in Q2 2026, its #231 holding.
  • Westfield Capital Management first reported a position in Amgen in Q3 2013 and has held it in 5 quarters since.
  • Westfield Capital Management's Amgen position peaked at $135M in Q3 2013.
  • 3,150 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Westfield Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.